UT-Southwestern Medical Center: Kidney Cancer Drug Shows Promise Against Dangerous Calcium Imbalance Caused by Tumors
October 10, 2025
October 10, 2025
DALLAS, Texas, Oct. 10 (TNSjou) -- The University of Texas Southwestern Medical Center issued the following news release:
* * *
Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors
Belzutifan, a drug developed by UTSW, may control life-threatening hypercalcemia
*
Elevated calcium levels in the blood - a complication of kidney cancers known as hypercalcemia - may be successfully treated with a class . . .
* * *
Kidney cancer drug shows promise against dangerous calcium imbalance caused by tumors
Belzutifan, a drug developed by UTSW, may control life-threatening hypercalcemia
*
Elevated calcium levels in the blood - a complication of kidney cancers known as hypercalcemia - may be successfully treated with a class . . .